February 05, 2019 IRVINE, Calif.–(BUSINESS WIRE)–Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft substitutes used for bone fusion procedures, has named Robert Baizer its new Chief Financial Officer. News of Baizer’s arrival comes on the heels of Biogennix reporting its 11,000th patient benchmark. Baizer has over 25 years of professional finance experience, …
All News
By Alex Kacik | February 4, 2019 Hospital prices are the main driver of U.S. healthcare spending inflation, and that trend should direct any policy changes going forward, according to a new study. For inpatient care, hospital prices grew 42% from 2007 to 2014 while physician prices rose 18%, according to researchers who studied the Health Care Cost …
February 4, 2019 – Miamisburg, Ohio Aerobiotix, Inc., a company providing innovative air quality systems to healthcare, is pleased to announce that Alan Donze has joined our team as Chief Commercialization Officer. Alan brings extensive experience as a global leader in the orthopedic and medical device space, with prior senior commercialization roles at Stryker, Smith …
KFAR SABA, Israel, Feb. 5, 2019 /PRNewswire/ — Seth L. Sherman, MD, a sports medicine orthopaedic surgeon at Missouri Orthopaedic Institute, recently became one of the first American surgeons to enroll patients in a clinical research study towards FDA approval of CartiHeal’s new knee cartilage repair implant. Agili-C™ is a novel implant designed to help patients with knee-cartilage defects …
by Larry Lacombe | Feb 4, 2019 It goes without saying that both regulation and accreditation are crucial to ensuring that healthcare providers and facilities uphold nationwide standards in patient care. While both hold healthcare providers accountable to their patients and community, strengthen patient safety and measure quality and safety of care, federal regulations require a great deal of …
KIRKLAND, QC, Feb. 4, 2019 /PRNewswire/ – Ortho Regenerative Technologies Inc. (“Ortho RTi” or the “Company”), an emerging Orthopaedic and Sports Medicine Technology company, today announced that the results of two key scientific studies validating its product’s ability to improve the repair of two distinct joint tissues – the rotator cuff tendon and articular cartilage. On Sunday the Rotator …
FEB 01 / Jeff Lagasse, Associate Editor New payment and delivery models are steadily seeping into the healthcare industry, and chief financial officers at hospitals and health systems across the country report a lack of confidence in their current financial tools’ ability to handle the changes. In fact, according to Kaufman Hall’s 2019 CFO Outlook: Healthcare report, …
January 31, 2019 ABERDEEN, Scotland–(BUSINESS WIRE)–SIRAKOSS Ltd, a developer of unique synthetic bone graft substitutes, announced today it has been granted CE Mark clearance in the European Union (EU) for Osteo3, a novel nanosynthetic bone graft substitute designed to improve patient healing, offering surgeons a more advanced solution for repairing bone fractures. Synthetic bone grafts …
KING OF PRUSSIA, Pa., Jan. 31, 2019 /PRNewswire/ — Camber Spine, a leading innovator in spine and medical technologies, today reported preliminary unaudited proprietary sales results (sales of products innovated and owned by the company) for the fourth quarter and full year ending December 31, 2018. These preliminary unaudited results include: Fourth quarter 2018, proprietary sales growth of …
© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1